Journal
JOURNAL OF IMMUNOLOGICAL METHODS
Volume 287, Issue 1-2, Pages 169-177Publisher
ELSEVIER
DOI: 10.1016/j.jim.2004.01.015
Keywords
Alzheimer's disease; CSF; ELISA GFAP; GFAP(SM126); normal pressure hydrocephalus; subarachnoid hemorrhage; traumatic brain injury
Categories
Ask authors/readers for more resources
Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein of the astrocyte, and body fluid levels of GFAP are an important tool for estimating astrogliosis and astrocytic activation in vivo. This paper presents a new sandwich ELISA allowing quantification of GFAP(SM126) from the cerebrospinal fluid (CSF). The sensitivity of the GFAP(SM126) ELISA is 5 pg/ml with a recovery of 94% and a mean within- and between-batch precision of 6% and 10%, respectively. The upper reference value for CSF GFAP(SM126) levels (9 pg/ml) was defined as the 95% cumulative frequency from 315 CSF samples. Based on this cut-off, a significantly higher proportion of patients with subarachnoid hemorrhage (100%), traumatic brain injury (100%), dementia (76%) and normal pressure hydrocephalus (85%) had pathologically elevated CSF GFAP(SM126) levels compared to patients with peripheral nervous system disorders (0%). In a critical review of the literature, we compare the analytical and clinical sensitivity of previous GFAP ELISA methods with particular reference to patients with dementia. (C) 2004 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available